milrinone has been researched along with Leukemia in 1 studies
Leukemia: A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006)
| Excerpt | Relevance | Reference |
|---|---|---|
| "We describe the case of a patient with refractory leukemia and end-stage CHF who developed severe dyspnea after discontinuation of milrinone." | 7.81 | Intensive symptom control of opioid-refractory dyspnea in congestive heart failure: Role of milrinone in the palliative care unit. ( Bruera, E; Elsayem, A; Montoya, M; Silvestre, J, 2015) |
| "We describe the case of a patient with refractory leukemia and end-stage CHF who developed severe dyspnea after discontinuation of milrinone." | 3.81 | Intensive symptom control of opioid-refractory dyspnea in congestive heart failure: Role of milrinone in the palliative care unit. ( Bruera, E; Elsayem, A; Montoya, M; Silvestre, J, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Silvestre, J | 1 |
| Montoya, M | 1 |
| Bruera, E | 1 |
| Elsayem, A | 1 |
1 other study available for milrinone and Leukemia
| Article | Year |
|---|---|
Intensive symptom control of opioid-refractory dyspnea in congestive heart failure: Role of milrinone in the palliative care unit.
Topics: Analgesics, Opioid; Dyspnea; Female; Heart Failure; Humans; Leukemia; Middle Aged; Milrinone; Pallia | 2015 |